Saitama-ken, Japan

Makoto Yanai


Average Co-Inventor Count = 7.7

ph-index = 7

Forward Citations = 252(Granted Patents)


Location History:

  • Kawagoe, JP (1989)
  • Saitama, JP (1992 - 1993)
  • Saitama-ken, JP (1997 - 2005)
  • Ohimachi, JP (1996 - 2006)

Company Filing History:


Years Active: 1989-2006

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Makoto Yanai: Innovator in Pharmaceutical Patents

Introduction

Makoto Yanai, based in Saitama-ken, Japan, is a prolific inventor with a remarkable portfolio of 19 patents. His contributions to the field of pharmaceuticals showcase his commitment to advancing medical science and improving healthcare outcomes through innovative solutions.

Latest Patents

One of Yanai's latest inventions is a propanolamine derivative featuring a 1,4-benzodioxane ring. This novel compound serves as an active ingredient in a medicament, addressing various health issues such as diabetes, obesity, hyperlipidemia, depression, respiratory diseases, and gastrointestinal disorders. The compound is characterized by a formula where R can vary, representing a hydrogen atom, halogen atom, hydroxy group, or various alkyl and alkoxy groups.

Additionally, Yanai has developed cyclic depsipeptides which are useful in promoting the production of apolipoprotein E, as well as serving as therapeutic agents for neurological damages and dementia. These compounds are meticulously synthesized using conventional peptide synthesis methods and include pharmacologically acceptable salts as part of their formulation.

Career Highlights

Throughout his career, Yanai has made significant strides in pharmaceutical research. He has been affiliated with notable companies such as Nisshin Flour Milling Co., Ltd. and Nisshin Seifun Group Inc., where he contributed to various innovative projects and research initiatives. His expertise in drug formulation and synthesis has led to advancements in the pharmaceutical industry.

Collaborations

Makoto Yanai has collaborated with esteemed colleagues such as Masashi Suzuki and Norio Oshida. These partnerships have been instrumental in driving forward the development of his patented inventions and expanding the horizons of pharmaceutical research. The collective efforts of Yanai and his coworkers have fostered an environment of innovation and scientific inquiry.

Conclusion

Makoto Yanai's dedication to innovation in the pharmaceutical realm is evident through his extensive patent portfolio and collaborative efforts. His inventions hold promise for various therapeutic applications, ultimately aiming to enhance the quality of life for patients suffering from a range of health conditions. As he continues to push the boundaries of medical science, Yanai remains a noteworthy figure in the world of inventors and healthcare innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…